Comparative Pharmacology
Head-to-head clinical analysis: EXCEDRIN MIGRAINE RELIEF versus MIDOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: EXCEDRIN MIGRAINE RELIEF versus MIDOL.
EXCEDRIN (MIGRAINE RELIEF) vs MIDOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Acetaminophen: inhibits COX enzymes centrally, reducing prostaglandin synthesis; Aspirin: irreversibly acetylates COX-1 and COX-2, inhibiting prostaglandin synthesis and platelet aggregation; Caffeine: adenosine receptor antagonist, enhances analgesic effect by vasoconstriction and increased drug absorption.
Midol is a combination product containing acetaminophen (analgesic/antipyretic via COX inhibition in CNS), caffeine (adenosine receptor antagonist), and pyrilamine (H1 antihistamine). The primary mechanism for dysmenorrhea is prostaglandin synthesis inhibition by acetaminophen.
2 tablets (250 mg acetaminophen, 250 mg aspirin, 65 mg caffeine) orally every 6 hours as needed, not to exceed 6 tablets in 24 hours.
Acetaminophen 500 mg, PAM Bromide 15 mg, Pyrilamine Maleate 15 mg: 2 tablets orally every 4-6 hours as needed for dysmenorrhea; maximum 10 tablets per day.
None Documented
None Documented
Acetaminophen: 2-3 hours (terminal); aspirin: 15-20 minutes (parent), salicylic acid: 2-3 hours (low dose), 15-30 hours (high dose); caffeine: 3-7 hours (adults). Clinical context: Half-lives prolonged in hepatic impairment, overdose, or renal failure.
Acetaminophen: 2-3 hours in adults; prolonged to 4-6 hours in neonates or hepatic impairment. Caffeine: 3-6 hours; prolonged in pregnancy or liver disease.
Renal excretion: acetaminophen ~3% unchanged, metabolites (glucuronide, sulfate, cysteine, mercapturate) ~85%; aspirin as salicylic acid ~10% unchanged, metabolites (salicyluric acid, glucuronides) ~75% renal; caffeine ~1-5% unchanged, metabolites (paraxanthine, theobromine, theophylline) ~70% renal. Biliary/fecal <5%.
Renal: >90% as acetaminophen glucuronide and sulfate conjugates; unchanged drug <5%. Biliary/fecal: <5%.
Category C
Category C
Analgesic Combination
Analgesic Combination